These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Theilgaard-Mönch K; Raaschou-Jensen K; Palm H; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619 [TBL] [Abstract][Full Text] [Related]
5. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells . Haas R; Murea S Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679 [TBL] [Abstract][Full Text] [Related]
6. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890 [TBL] [Abstract][Full Text] [Related]
7. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies. Dabusti M; Lanza F; Campioni D; Castagnari B; Tieghi A; Moretti S; Punturieri M; De Angeli C; Spanedda R; Ferrazzi E; Castoldi G J Hematother Stem Cell Res; 2003 Aug; 12(4):425-34. PubMed ID: 12965079 [TBL] [Abstract][Full Text] [Related]
8. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [TBL] [Abstract][Full Text] [Related]
10. Long-term repopulating hematopoietic stem cells and "side population" in human steady state peripheral blood. Brunet de la Grange P; Vlaski M; Duchez P; Chevaleyre J; Lapostolle V; Boiron JM; Praloran V; Ivanovic Z Stem Cell Res; 2013 Jul; 11(1):625-33. PubMed ID: 23651585 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells. Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733 [TBL] [Abstract][Full Text] [Related]
12. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection. Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543 [TBL] [Abstract][Full Text] [Related]
13. A unique population of CD34+ cells in cord blood. Nimgaonkar MT; Roscoe RA; Persichetti J; Rybka WB; Winkelstein A; Ball ED Stem Cells; 1995 Mar; 13(2):158-66. PubMed ID: 7540469 [TBL] [Abstract][Full Text] [Related]
14. Obtaining of CD34+ cells from healthy blood donors: development of a rapid and efficient procedure using leukoreduction filters. Peytour Y; Guitart A; Villacreces A; Chevaleyre J; Lacombe F; Ivanovic Z; Praloran V Transfusion; 2010 Oct; 50(10):2152-7. PubMed ID: 20456706 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. Steen R; Tjønnfjord GE; Egeland T J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606 [TBL] [Abstract][Full Text] [Related]
16. Comparison of CD34+ subsets and clonogenicity in human bone marrow, granulocyte colony-stimulating factor-mobilized peripheral blood, and cord blood. Cho SH; Chung IJ; Lee JJ; Park ML; Kim HJ J Korean Med Sci; 1999 Oct; 14(5):520-5. PubMed ID: 10576147 [TBL] [Abstract][Full Text] [Related]
17. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts. Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266 [TBL] [Abstract][Full Text] [Related]
18. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation. De Bruyn C; Delforge A; Lagneaux L; Bron D Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580 [TBL] [Abstract][Full Text] [Related]
19. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]